Overdiagnosed: How Profit Reshaped ADHD Care
From original sourcesGeneral information from the sources it names, not personalized advice.
Built from the creator's sources. How Capxule uses AI
About this Capsule
Rising ADHD diagnoses track less with patient need than with an industry that profits from every prescription. Against the mainstream default of medication first, this take says drug-company influence biases research and guidelines, and that community-based and behavioral approaches address root causes without pathologizing normal behavior. Skepticism toward profit-driven diagnosis is the starting point for more honest mental health care.
Questions this capsule answers
Tap any question to get it answered inside the capsule, free.
Generic AI vs AI with This Capsule
Preview“Why do ADHD diagnosis rates vary so wildly between states and countries if it's a biological brain disorder?”
Generic AI
“ADHD can be a biologically based neurodevelopmental disorder and still have diagnosis rates that vary widely. The key is that “ADHD diagnosis rate” is not the same thing as “true underlying rate of ADHD traits in the population.”
Several things affect whether a person with ADHD-like impairments actually gets diagnosed:
1. No simple biological test
ADHD is associated with brain development, genetics, dopamine/norepinephrine systems, executive function, etc., but diagnosis is still based on behavior, impairment, history, and context, not a blood test or brain scan. That leaves room for variation in clinical judgment and local practice.
2. Different diagnostic rules and thresholds
Countries and clinicians may use different systems, mainly:
- DSM criteria, common in the U.S.
- ICD criteria, historically more restrictive in many countries
Some systems require more...”
This Capsule
“The clue is in the extremes: stimulant prescription rates range from about 1 in 100 children in Hawaii to nearly 1 in 7 in Alabama. The human brain does not mutate that dramatically at state borders. What changes is the machinery around the child: diagnostic thresholds, school incentives, insurance rules, teacher referrals, pharmaceutical marketing, cultural norms, and access to behavioral care.
ADHD may involve real neurodevelopmental differences, but the rate at which those differences become a diagnosis is socially filtered. Several forces drive the variation:
- Diagnosis is behavior-based, not biomarker-based There is no blood test, scan, or “pharmacological litmus test” for ADHD. Diagnosis relies heavily on parent and teacher reports, symptom checklists, and clinician judgment. That makes rates sensitive to local expectations about what counts as “too restless,” ...”
Related in Health
Bahrain Nursing Licensure Examination (BNLE)
A handcrafted AI study companion for nurses seeking NHRA licensure in Bahrain: the official PQR rules, the BNLE exam pathway, the scope of practice, and scope-grounded clinical teaching with original practice questions.
Iraqi Board Medical Specialization Exam
A handcrafted AI study companion for doctors preparing for the Iraqi Board for Medical Specializations: the Board route, competitive entry, specialty training, exams, logbook and research, plus clinical teaching across internal medicine, family medicine, surgery, radiology, anaesthesia and intensive care, with original practice questions.
Qatar QCHP Physician Qualifying Exam
Pass the Qatar General Practitioner qualifying exam first time: the official QCHP rules, the DHP physician blueprint, and the medicine it tests, taught from the Department of Healthcare Professions sources.
Oman OMSB Physician Licensing Exam (OEGP)
A handcrafted AI study companion for the Omani Examination for General Practitioners (OEGP): the official OMSB blueprint, the Pearson VUE booking route, and real general practice teaching across all six domains, with 60 original practice questions.